2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells

Journal of Experimental Medicine

Volumn 199, Issue 9, 2004, Pages 1245-1254

  Lee, Kyung Mi ^a   McNerney, Megan E ^b   Stepp, Susan E ^c   Mathew, Porunelloor A ^d   Schatzle, John D ^e   Bennett, Michael ^e   Kumar, Vinay ^b  

^a Korea University College of Medicine   (South Korea)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD150; CD48; IFN ; Innate immunity; Tumor

Indexed keywords

2B4 ANTIGEN; ANTIGEN; CD150 ANTIGEN; CD48 ANTIGEN; GAMMA INTERFERON; PROTEIN; RETROVIRUS VECTOR; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ACTIVATION; CONTROLLED STUDY; CROSS LINKING; CYTOLYSIS; CYTOTOXICITY; EX VIVO STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM TUMOR; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANIMALS; ANTIGENS, CD; CYTOTOXICITY, IMMUNOLOGIC; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; RECEPTORS, IMMUNOLOGIC;

EID: 2442428477     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031989     Document Type: Article

References (57)

1. Biron, C.A., K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
2. Lanier, L.L. 1995. The role of natural killer cells in transplantation. Curr. Opin. Immunol. 7:626-631.
3. Lanier, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-393.
4. McQueen, K.L., and P. Parham. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14:615-621.
5. Lanier, L.L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2:23-27.
6. Sidorenko, S.P., and E.A. Clark. 2003. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4:19-24.
7. Mathew, P.A., B.A. Garni-Wagner, K. Land, A. Takashima, E. Stoneman, M. Bennett, and V. Kumar. 1993. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151:5328-5337.
8. Stepp, S.E., J.D. Schatzle, M. Bennett, V. Kumar, and P.A. Mathew. 1999. Gene structure of the murine NK cell receptor 2B4: presence of two alternatively spliced isoforms with distinct cytoplasmic domains. Eur. J. Immunol. 29:2392-2399.
9. Boles, K.S., H. Nakajima, M. Colonna, S.S. Chuang, S.E. Stepp, M. Bennett, V. Kumar, and P.A. Mathew. 1999. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens. 54:27-34.
10. Garni-Wagner, B.A., A. Purohit, P.A. Mathew, M. Bennett, and V. Kumar. 1993. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151:60-70.
11. Valiante, N.M., and G. Trinchieri. 1993. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178:1397-1406.
12. Schuhmachers, G., K. Ariizumi, P.A. Mathew, M. Bennett, V. Kumar, and A. Takashima. 1995. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. J. Invest. Dermatol. 105:592-596.
13. Nakajima, H., M. Cella, H. Langen, A. Friedlein, and M. Colonna. 1999. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29: 1676-1683.
14. Brown, M.H., K. Boles, P.A. van der Merwe, V. Kumar, P.A. Mathew, and A.N. Barclay. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188:2083-2090.
15. Latchman, Y., P.F. McKay, and H. Reiser. 1998. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161:5809-5812.
16. Yokoyama, S., D. Staunton, R. Fisher, M. Amiot, J. Fortin, and D. Thorley-Lawson. 1991. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J. Immunol. 146:2192-2200.
17. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M.G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:462-469.
18. Morra, M., J. Lu, F. Poy, M. Martin, J. Sayos, S. Calpe, C. Gullo, D. Howie, S. Rietdijk, A. Thompson, et al. 2001. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J. 20:5840-5852.
19. Purtilo, D.T., C.K. Cassel, J.P. Yang, and R. Harper. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1:935-940.
20. Purtilo, D.T., J.P. Yang, S. Allegra, D. DeFlorio, L.M. Hutt, M. Soltani, and G. Vawter. 1977. Hematopathology and pathogenesis of the X-linked recessive lymphoproliferative syndrome. Am. J. Med. 62:225-233.
21. Coffey, A.J., R.A. Brooksbank, O. Brandau, T. Oohashi, G.R. Howell, J.M. Bye, A.P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:129-135.
22. Nichols, K.E., D.P. Harkin, S. Levitz, M. Krainer, K.A. Kolquist, C. Genovese, A. Bernard, M. Ferguson, L. Zuo, E. Snyder, et al. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA. 95:13765-13770.
23. Tangye, S.G., S. Lazetic, E. Woollatt, G.R. Sutherland, L.L. Lanier, and J.H. Phillips. 1999. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162:6981-6985.
24. Sivori, S., M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA. 99:4526-4531.
25. Sayos, J., K.B. Nguyen, C. Wu, S.E. Stepp, D. Howie, J.D. Schatzle, V. Kumar, C.A. Biron, and C. Terhorst. 2000. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol. 12:1749-1757.
26. Benoit, L., X. Wang, H.F. Pabst, J. Dutz, and R. Tan. 2000. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165:3549-3553.
27. Nakajima, H., M. Cella, A. Bouchon, H.L. Grierson, J. Lewis, C.S. Duckett, J.I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:3309-3318.
28. Tangye, S.G., J.H. Phillips, L.L. Lanier, and K.E. Nichols. 2000. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165:2932-2936.
29. Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H.D. Ochs, H. Wolf, J.Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346.
30. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1609-1614.
31. Lee, K.M., S. Bhawan, T. Majima, H. Wei, M.I. Nishimura, H. Yagita, and V. Kumar. 2003. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J. Immunol. 170:4881-4885.
32. Roszkowski, J.J., D.C. Yu, M.P. Rubinstein, M.D. McKee, D.J. Cole, and M.I. Nishimura. 2003. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J. Immunol. 170:2582-2589.
33. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
34. Karre, K. 2002. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55:221-228.
35. George, T.C., J.R. Ortaldo, S. Lemieux, V. Kumar, and M. Bennett. 1999. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J. Immunol. 163:1859-1867.
36. Rabinovich, B.A., J. Li, J. Shannon, R. Hurren, J. Chalupny, D. Cosman, and R.G. Miller. 2003. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170:3572-3576.
37. Rajagopalan, S., J. Fu, and E.O. Long. 2001. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167:1877-1881.
38. Chuang, S.S., P.R. Kumaresan, and P.A. Mathew. 2001. 2B4 (CD244) -mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways. J. Immunol. 167:6210-6216.
39. Schatzle, J.D., S. Sheu, S.E. Stepp, P.A. Mathew, M. Bennett, and V. Kumar. 1999. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl. Acad. Sci. USA. 96:3870-3875.
40. Bouchon, A., M. Cella, H.L. Grierson, J.I. Cohen, and M. Colonna. 2001. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167:5517-5521.
41. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A.M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174:1393-1398.
42. Esplugues, E., D. Sancho, J. Vega-Ramos, C. Martinez, U. Syrbe, A. Hamann, P. Engel, F. Sanchez-Madrid, and P. Lauzurica. 2003. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197:1093-1106.
43. Tangye, S.G., H. Cherwinski, L.L. Lanier, and J.H. Phillips. 2000. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37:493-501.
44. Sivori, S., S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2000. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:787-793.
45. Faure, M., and E.O. Long. 2002. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168:6208-6214.
46. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126.
47. Vitale, M., J. Zimmer, R. Castriconi, D. Hanau, L. Donato, C. Bottino, L. Moretta, H. de la Salle, and A. Moretta. 2002. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood. 99:1723-1729.
48. Dorfman, J.R., J. Zerrahn, M.C. Coles, and D.H. Raulet. 1997. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1-mice. J. Immunol. 159: 5219-5225.
49. Iizuka, K., O.V. Naidenko, B.F. Plougastel, D.H. Fremont, and W.M. Yokoyama. 2003. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4:801-807.
50. Blue, M.L., H. Levine, J.F. Daley, K.R. Branton, Jr., and S.F. Schlossman. 1989. Expression of CD1 and class I MHC antigens by human thymocytes. J. Immunol. 142:2714-2720.
51. Haynes, B.F., and C.S. Heinly. 1995. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J. Exp. Med. 181:1445-1458.
52. Czar, M.J., E.N. Kersh, L.A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C.S. Duckett, R. Ahmed, et al. 2001. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA. 98: 7449-7454.
53. Latour, S., G. Gish, C.D. Helgason, R.K. Humphries, T. Pawson, and A. Veillette. 2001. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2:681-690.
54. Chambers, B.J., M. Salcedo, and H.G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 5:311-317.
55. Ferlazzo, G., M.L. Tsang, L. Moretta, G. Melioli, R.M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343-351.
56. Piccioli, D., S. Sbrana, E. Melandri, and N.M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:335-341.
57. Tissot, C., C. Kebouissou, B. Klein, and N. Mechti. 1997. Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules. J. Interferon Cytokine Res. 17:17-26.